October 1st 2024
The Astellas chief commercial officer discusses the impact that the increase in global and local connectivity has had on commercialization, among other trends.
September 16th 2024
September 11th 2024
Fighting the Drop in Vaccination Rates: Q&A with Gregg Sylvester
July 26th 2024An unexpected consequence of the COVID 19 pandemic has been a loss in trust of vaccines. Over the past three flu seasons, there has been a drop in vaccination rates that is alarming experts. Dr. Gregg Sylvester, chief health officer at CSL Seqirus, spoke with Pharmaceutical Executive about the causes of the decline and how important it is to get the rates back to normal.
2024 Pharm Exec Top 50 Companies
June 14th 2024Highlighted by notable company and product maneuvering at the top and the continued dramatic growth of therapeutic settings such as GLP-1s, Pharm Exec’s latest listing of the top global biopharma sales producers is proof-positive of an industry in transition.